Filing Details

Accession Number:
0001615219-22-000018
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-09 16:01:55
Reporting Period:
2022-03-03
Accepted Time:
2022-03-09 16:01:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1615219 Salarius Pharmaceuticals Inc. SLRX Pharmaceutical Preparations (2834) 465087339
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1769331 J. David Arthur C/O Salarius Pharmaceuticals, Inc.
2450 Holcome Blvd., Suite X
Houston TX 77021
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-03 139,488 $0.39 249,674 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The Registrant issued these shares to the reporting person as part of his bonus; which shares were issued in lieu of net cash compensation. The shares were issued at the fair market value of the Registrants common stock on the date of grant.